ENG 
CZE 
gb PHARM Warfarin
Kit slouží k detekci mutací CYP2C9*2, CYP2C9*3 a VKORC1 G1639A v lidské genomové DNA. Kit je založen na real-time PCR s využitím fluorescenčně značených sond.
The beginning of a new year at GENERI BIOTECH represents more than just a change in the calendar. It marks a time when our projects, manufacturing activities, and collaborations with partners both in the Czech Republic and abroad are fully reactivated. We have returned to full operational mode and are ready to build on everything we have developed together over the past period.
We hope you enjoyed a peaceful holiday season with your families and had the opportunity to recharge for the year ahead. Our teams are now back to standard operations across all departments — from research and development and manufacturing to quality control, logistics, and customer support. All teams are fully prepared to assist you with any requirements, whether related to the supply of IVD diagnostic kits, molecular biology products, or GMP/GLP testing services.
We view 2026 as another important step in the long-term strategic development of our company. You can already choose from our full product portfolio and look forward to additional innovations that we will be introducing throughout the year.
We sincerely thank all our customers and partners for their trust and look forward to continued cooperation in 2026.
Leona Hofmeisterová
